Cargando…
GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway
Gemcitabine-based chemotherapy is the first-line treatment for pancreatic cancer. However, chemoresistance is a major obstacle to drug efficacy, leading to poor prognosis. Little progress has been achieved although multiple mechanisms are investigated. Therefore, effective strategies are urgently ne...
Autores principales: | Chang, Zhenyu, Zhang, Yanan, Liu, Jie, Guan, Chengjian, Gu, Xinjin, Yang, Zelong, Ye, Qinong, Ding, Lihua, Liu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481023/ https://www.ncbi.nlm.nih.gov/pubmed/31093285 http://dx.doi.org/10.1155/2019/9474273 |
Ejemplares similares
-
The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer
por: Zhang, Yanan, et al.
Publicado: (2016) -
MiR-3180 inhibits hepatocellular carcinoma growth and metastasis by targeting lipid synthesis and uptake
por: Hong, Jie, et al.
Publicado: (2023) -
miR-1224-3p Promotes Breast Cancer Cell Proliferation and Migration through PGM5-Mediated Aerobic Glycolysis
por: Ran, Fang, et al.
Publicado: (2021) -
SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis
por: Zhang, Yanan, et al.
Publicado: (2022) -
Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly
por: Gu, Xinjin, et al.
Publicado: (2016)